Cargando…
Complications of Pancreatic Resection Reduced by Somatostatin
Autor principal: | Imrie, C. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423679/ https://www.ncbi.nlm.nih.gov/pubmed/8260440 http://dx.doi.org/10.1155/1993/64710 |
Ejemplares similares
-
The combination of ulinastatin and somatostatin reduces complication rates in acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials
por: Horváth, István László, et al.
Publicado: (2022) -
Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients
por: ZHAO, LI-NA, et al.
Publicado: (2014) -
Human pancreatic cancer cell lines do not express receptors for somatostatin.
por: Gillespie, J., et al.
Publicado: (1992) -
Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon
por: Collins, S. C., et al.
Publicado: (2008) -
Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)